rs33967815
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_032447.5(FBN3):c.4840G>A(p.Gly1614Ser) variant causes a missense change. The variant allele was found at a frequency of 0.287 in 1,612,494 control chromosomes in the GnomAD database, including 72,056 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_032447.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN3 | NM_032447.5 | c.4840G>A | p.Gly1614Ser | missense_variant | 39/64 | ENST00000600128.6 | NP_115823.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN3 | ENST00000600128.6 | c.4840G>A | p.Gly1614Ser | missense_variant | 39/64 | 1 | NM_032447.5 | ENSP00000470498 | ||
FBN3 | ENST00000270509.6 | c.4840G>A | p.Gly1614Ser | missense_variant | 38/63 | 1 | ENSP00000270509 | |||
FBN3 | ENST00000601739.5 | c.4840G>A | p.Gly1614Ser | missense_variant | 39/64 | 1 | ENSP00000472324 | |||
FBN3 | ENST00000651877.1 | c.4966G>A | p.Gly1656Ser | missense_variant | 39/64 | ENSP00000498507 | P1 |
Frequencies
GnomAD3 genomes AF: 0.227 AC: 34488AN: 151834Hom.: 4897 Cov.: 31
GnomAD3 exomes AF: 0.244 AC: 61177AN: 251112Hom.: 8794 AF XY: 0.251 AC XY: 34067AN XY: 135696
GnomAD4 exome AF: 0.293 AC: 428578AN: 1460542Hom.: 67163 Cov.: 33 AF XY: 0.292 AC XY: 212467AN XY: 726626
GnomAD4 genome AF: 0.227 AC: 34478AN: 151952Hom.: 4893 Cov.: 31 AF XY: 0.221 AC XY: 16437AN XY: 74250
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
FBN3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at